Page last updated: 2024-11-11

4,7,10,13,16,19-docosahexaenoic acid dopamine conjugate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

NMI 8739: structure given in first source; RN given refers to all-cis isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6443994
CHEMBL ID343736
SCHEMBL ID11888439
MeSH IDM0260368

Synonyms (15)

Synonym
dha-da conjugate
NCGC00161234-02
nmi 8739
CHEMBL343736
(4z,7z,10z,13z,16z,19z)-n-[2-(3,4-dihydroxyphenyl)ethyl]docosa-4,7,10,13,16,19-hexaenamide
129024-87-9
n-(2-(3,4-dihydroxyphenyl)ethyl)-4,7,10,13,16,19-docosahexaenamide
4,7,10,13,16,19-docosahexaenoic acid dopamine conjugate
nmi-8739
SCHEMBL11888439
CS-0021682
HY-101540
MS-28532
n-docosahexaenoyl dopamine
AKOS040733009
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
polyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)Potency1.99531.000012.232631.6228AID1452
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID42891Concentration required to displace 0.4 nM [3H]SR-141,716A from CB1 receptor in rat brain preparations in the presence of 0.1 mM phenylmethyl sulfonyl fluoride; Not tested2001Bioorganic & medicinal chemistry letters, Feb-26, Volume: 11, Issue:4
Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine.
AID193981Tested to induce analgesia in hot plate test, expressed as percent of latency time (p<0.05)2001Bioorganic & medicinal chemistry letters, Feb-26, Volume: 11, Issue:4
Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine.
AID183630Tested for percent immobility time in the ring test, expressed as % of control (p<0.01)2001Bioorganic & medicinal chemistry letters, Feb-26, Volume: 11, Issue:4
Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine.
AID195482Tested for decrease in rectal temperature 10 min after ip injection2001Bioorganic & medicinal chemistry letters, Feb-26, Volume: 11, Issue:4
Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine.
AID195483Tested for decrease in rectal temperature 5 min after ip injection2001Bioorganic & medicinal chemistry letters, Feb-26, Volume: 11, Issue:4
Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine.
AID1616997Antiallergic activity in rat RBL2H3 cells assessed as inhibition of DNP-HSA-mediated degranulation by measuring decrease in beta-hexosaminidase activity preincubated for 30 mins followed by DNP-HSA stimulation and measured after 30 mins by 4-nitrophenyl 22019Journal of medicinal chemistry, 11-14, Volume: 62, Issue:21
Structure-Activity Relationships of Fish Oil Derivatives with Antiallergic Activity in Vitro and in Vivo.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's2 (20.00)29.6817
2010's4 (40.00)24.3611
2020's3 (30.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.63 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]